SCHEMBL7984762

SCHEMBL7984762

CC(C)(C)OC(=O)Nc1cccc(-c2nc(=O)c3c(ncn3Cc3ccccc3)[nH]2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 2/20 0.45
PARN O95453 1/20 0.42
CNOT7 Q9UIV1 1/20 0.42
TLR7 Q9NYK1 1/20 0.41
MAPT P10636 4/20 0.40
KDM4E B2RXH2 3/20 0.39
MMP2 P08253 3/20 0.39
MMP9 P14780 3/20 0.39
MMP8 P22894 3/20 0.39
CYP17A1 P05093 1/20 0.39
RIPK3 Q9Y572 1/20 0.39
CDK9 P50750 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.39
NPY1R P25929 1/20 0.39
MEN1 O00255 2/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 2/20 0.39
POLB P06746 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984489 0.90 P2RX7 (0.45) P2RX7PARNCNOT7CYP17A1CDK9
SCHEMBL7984759 0.87 HPGD (0.49) P2RX7TLR7MAPTKDM4EMMP2
SCHEMBL7974157 0.83 BRD4 (0.44) P2RX7PARNCNOT7ALDH1A1SMN1; SMN2
SCHEMBL7985342 0.79 CNOT7 (0.51) PARNCNOT7ALDH1A1KMT2ASMN1; SMN2
SCHEMBL7988597 0.79 PARN (0.48) P2RX7PARNCNOT7MAPTALDH1A1
SCHEMBL7975271 0.79 CNOT7 (0.56) PARNCNOT7ALDH1A1KMT2ASMN1; SMN2
SCHEMBL7974586 0.79 GAA (0.52) P2RX7PARNCNOT7MAPTGAA
SCHEMBL7984663 0.78 CNOT7 (0.49) PARNCNOT7KDM4EMEN1ALDH1A1
SCHEMBL7974015 0.78 PARN (0.49) PARNCNOT7ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL7985482 0.78 PAX8 (0.43) P2RX7PARNCNOT7ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed